Crossmark

Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience

Crossref DOI link: https://doi.org/10.1186/s12890-016-0290-5

Published Online: 2016-08-25

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Caminati, M.

Senna, G.

Stefanizzi, G.

Bellamoli, R.

Longhi, S.

Chieco-Bianchi, F.

Guarnieri, G.

Tognella, S.

Olivieri, M.

Micheletto, C.

Festi, G.

Bertocco, E.

Mazza, M.

Rossi, A.

Vianello, A.